A detailed history of Dimensional Fund Advisors LP transactions in Immutep LTD stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 70,005 shares of IMMP stock, worth $155,411. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,005
Previous 70,005 -0.0%
Holding current value
$155,411
Previous $163,000 14.11%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$1.75 - $2.37 $20,865 - $28,257
-11,923 Reduced 14.55%
70,005 $133,000
Q1 2023

May 12, 2023

BUY
$1.63 - $2.06 $17,625 - $22,274
10,813 Added 15.2%
81,928 $137,000
Q4 2022

Feb 09, 2023

BUY
$1.6 - $2.53 $4,366 - $6,904
2,729 Added 3.99%
71,115 $124,000
Q3 2022

Nov 10, 2022

BUY
$1.56 - $2.29 $16,459 - $24,161
10,551 Added 18.24%
68,386 $106,000
Q2 2022

Aug 12, 2022

BUY
$1.96 - $3.09 $55,932 - $88,179
28,537 Added 97.4%
57,835 $117,000
Q1 2022

May 13, 2022

BUY
$2.3 - $3.61 $67,385 - $105,765
29,298 New
29,298 $80,000

Others Institutions Holding IMMP

About IMMUTEP Ltd


  • Ticker IMMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,000
  • Market Cap $192M
  • Description
  • Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...
More about IMMP
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.